BlackThorn Therapeutics Closes $76 Million Series B to Advance Targeted Therapeutics for Mental Health
– Company Also Expands Board of Directors and Executive Management Team with Key Appointments – SAN FRANCISCO–(BUSINESS WIRE)–BlackThorn Therapeutics, a…